CEPH individuals are representative of the European American population: implications for pharmacogenetics

Author： Meucci Melissa A   Marsh Sharon   Watters James W   McLeod Howard L  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.1, 2005-01, pp. : 59-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Five batches representative of Ontario-grown American ginseng root produce comparable reductions of postprandial glycemia in healthy individuals

By Dascalu Anamaria   Sievenpiper John L.   Jenkins Alexandra L.   Stavro Mark P.   Leiter Lawrence A.   Arnason John T.   Vuksan Vladimir  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 9, 2007-09 ,pp. : 856-864

NRC Research Press

Access to resources Recommend Favorite

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics

By Tarr Philip E   Rotger Margalida   Telenti Amalio  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 587-594

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of Oxazaphosphorines and its Clinical Implications

By  

Current Pharmacogenomics, Vol. 5, Iss. 2, 2007-06 ,pp. : 143-156

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of Pharmacogenetics for Oral Anticoagulants Metabolism

By  

Current Drug Metabolism, Vol. 10, Iss. 6, 2009-07 ,pp. : 632-642

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients

By Moes Dirk Jan A.R.   Press Rogier R.   >  

Clinical Pharmacokinetics, Vol. 51, Iss. 7, 2012-07 ,pp. : 467-480

Adis International

Access to resources Recommend Favorite